Cytarabine (DBL) is a medicine containing the active ingredient(s) cytarabine. On this page you will find out more about Cytarabine (DBL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cytarabine
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Cytarabine (DBL) 500 mg/5 mL injection solution, 5 mL vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Cytarabine may be used alone or in combination with other chemotherapeutic agents. It is indicated for induction of remission of leukaemia, particularly for acute myeloid leukaemia, in adults and children. Cytarabine has been used for remission induction in acute lymphocytic leukaemia, chronic myeloid leukaemia and erythroleukaemia; and in the treatment and maintenance therapy of meningeal leukaemia and other meningeal neoplasms.
Table of characteristics
|Visual appearance||Clear colourless solution|
|Dosage Form||Injection, solution|
|Route of administration||Intravenous|
1 x 5mL (single onco vial): Prescription Only Medicine, or Prescription Animal Remedy
1x500mg/5mL: Prescription Only Medicine, or Prescription Animal Remedy
1x500mg/5mL(E): Not scheduled. Not considered by committee
There is one type of pack available.
Pack type 1
|Storage temperature||Store between 15-25 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||18 Months|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Cytarabine (DBL) | myVMC
Cytarabine used to treat leukaemia and brain neoplasms. It is an antineoplastic agent, bone marrow suppressant and immunosuppressant.
Read more on myVMC – Virtual Medical Centre website
DBL Cytarabine Injection (Solution for injection) - myDr.com.au
DBL Cytarabine Injection (Solution for injection) - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results